Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects

Published:2021 Issue:3 Volume:29 Page:171
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Moon Seol Ju¹^ORCID,Kim Yunjeong¹^ORCID,Jeon Ji-Young¹^ORCID,Park Shin-Jung²,Kwak Yong-Geun³⁴^ORCID,Kim Min-Gul¹³⁴^ORCID

Affiliation:

1. Center for Clinical Pharmacology and Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju, Korea.

2. Research Institute, Chong Kun Dang Pharmaceutical Corp., Yongin, Korea.

3. Department of Pharmacology, School of Medicine, Jeonbuk National University, Jeonju, Korea.

4. Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Korea.

Publisher

Korean Society for Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical)

Link

https://tcpharm.org/pdf/10.12793/tcp.2021.29.e17

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality by design-assisted development of D-α-tocopherol polyethylene glycol 1000 succinate-incorporated gefitinib-loaded cationic liposome(s);Therapeutic Delivery;2023-12

2. Solid Dispersions of Gefitinib with D-α-Tocopherol Polyethylene Glycol-1000 Succinate and 2-Hydroxypropyl β-Cyclodextrin Complex Improved Their Solubility, Dissolution and Apoptosis against A549 Cells;Applied Sciences;2023-09-29

3. Pharmacokinetics, bioequivalence, and safety studies of gefitinib tablet formulations: A randomized, open-label, two-period, two-sequence crossover study in Chinese healthy volunteers;Journal of Drug Delivery Science and Technology;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3